F Kuo1, N N Ng1, S Nagpal2, E L Pollom3, S Soltys3, M Hayden-Gephart4, G Li4, D E Born5, M Iv6. 1. From the Department of Radiology, Division of Neuroimaging and Neurointervention (F.K., N.N.N., M.I.). 2. Departments of Neurology (Neuro-Oncology) (S.N.). 3. Radiation Oncology (E.L.P., S.S.). 4. Neurosurgery (M.H.-G., G.L.). 5. Pathology (D.E.B.), Stanford University, Stanford, California. 6. From the Department of Radiology, Division of Neuroimaging and Neurointervention (F.K., N.N.N., M.I.) miv@stanford.edu.
Abstract
BACKGROUND AND PURPOSE: Differentiation between tumor and radiation necrosis in patients with brain metastases treated with stereotactic radiosurgery is challenging. We hypothesized that MR perfusion and metabolic metrics can differentiate radiation necrosis from progressive tumor in this setting. MATERIALS AND METHODS: We retrospectively evaluated MRIs comprising DSC, dynamic contrast-enhanced, and arterial spin-labeling perfusion imaging in subjects with brain metastases previously treated with stereotactic radiosurgery. For each lesion, we obtained the mean normalized and standardized relative CBV and fractional tumor burden, volume transfer constant, and normalized maximum CBF, as well as the maximum standardized uptake value in a subset of subjects who underwent FDG-PET. Relative CBV thresholds of 1 and 1.75 were used to define low and high fractional tumor burden. RESULTS: Thirty subjects with 37 lesions (20 radiation necrosis, 17 tumor) were included. Compared with radiation necrosis, tumor had increased mean normalized and standardized relative CBV (P = .002) and high fractional tumor burden (normalized, P = .005; standardized, P = .003) and decreased low fractional tumor burden (normalized, P = .03; standardized, P = .01). The area under the curve showed that relative CBV (normalized = 0.80; standardized = 0.79) and high fractional tumor burden (normalized = 0.77; standardized = 0.78) performed the best to discriminate tumor and radiation necrosis. For tumor prediction, the normalized relative CBV cutoff of ≥1.75 yielded a sensitivity of 76.5% and specificity of 70.0%, while the standardized cutoff of ≥1.75 yielded a sensitivity of 41.2% and specificity of 95.0%. No significance was found with the volume transfer constant, normalized CBF, and standardized uptake value. CONCLUSIONS: Increased relative CBV and high fractional tumor burden (defined by a threshold relative CBV of ≥1.75) best differentiated tumor from radiation necrosis in subjects with brain metastases treated with stereotactic radiosurgery. Performance of normalized and standardized approaches was similar.
BACKGROUND AND PURPOSE: Differentiation between tumor and radiation necrosis in patients with brain metastases treated with stereotactic radiosurgery is challenging. We hypothesized that MR perfusion and metabolic metrics can differentiate radiation necrosis from progressive tumor in this setting. MATERIALS AND METHODS: We retrospectively evaluated MRIs comprising DSC, dynamic contrast-enhanced, and arterial spin-labeling perfusion imaging in subjects with brain metastases previously treated with stereotactic radiosurgery. For each lesion, we obtained the mean normalized and standardized relative CBV and fractional tumor burden, volume transfer constant, and normalized maximum CBF, as well as the maximum standardized uptake value in a subset of subjects who underwent FDG-PET. Relative CBV thresholds of 1 and 1.75 were used to define low and high fractional tumor burden. RESULTS: Thirty subjects with 37 lesions (20 radiation necrosis, 17 tumor) were included. Compared with radiation necrosis, tumor had increased mean normalized and standardized relative CBV (P = .002) and high fractional tumor burden (normalized, P = .005; standardized, P = .003) and decreased low fractional tumor burden (normalized, P = .03; standardized, P = .01). The area under the curve showed that relative CBV (normalized = 0.80; standardized = 0.79) and high fractional tumor burden (normalized = 0.77; standardized = 0.78) performed the best to discriminate tumor and radiation necrosis. For tumor prediction, the normalized relative CBV cutoff of ≥1.75 yielded a sensitivity of 76.5% and specificity of 70.0%, while the standardized cutoff of ≥1.75 yielded a sensitivity of 41.2% and specificity of 95.0%. No significance was found with the volume transfer constant, normalized CBF, and standardized uptake value. CONCLUSIONS: Increased relative CBV and high fractional tumor burden (defined by a threshold relative CBV of ≥1.75) best differentiated tumor from radiation necrosis in subjects with brain metastases treated with stereotactic radiosurgery. Performance of normalized and standardized approaches was similar.
Authors: James R Knitter; William K Erly; Baldassarre D Stea; Gerald M Lemole; Isabelle M Germano; Amish H Doshi; Kambiz Nael Journal: AJR Am J Roentgenol Date: 2018-04-30 Impact factor: 3.959
Authors: J M Hoxworth; J M Eschbacher; A C Gonzales; K W Singleton; G D Leon; K A Smith; A M Stokes; Y Zhou; G L Mazza; A B Porter; M M Mrugala; R S Zimmerman; B R Bendok; D P Patra; C Krishna; J L Boxerman; L C Baxter; K R Swanson; C C Quarles; K M Schmainda; L S Hu Journal: AJNR Am J Neuroradiol Date: 2020-03-12 Impact factor: 3.825
Authors: K M Schmainda; M A Prah; L S Hu; C C Quarles; N Semmineh; S D Rand; J M Connelly; B Anderies; Y Zhou; Y Liu; B Logan; A Stokes; G Baird; J L Boxerman Journal: AJNR Am J Neuroradiol Date: 2019-03-28 Impact factor: 3.825
Authors: M Iv; X Liu; J Lavezo; A J Gentles; R Ghanem; S Lummus; D E Born; S G Soltys; S Nagpal; R Thomas; L Recht; N Fischbein Journal: AJNR Am J Neuroradiol Date: 2019-09-12 Impact factor: 3.825
Authors: M A Prah; S M Stufflebeam; E S Paulson; J Kalpathy-Cramer; E R Gerstner; T T Batchelor; D P Barboriak; B R Rosen; K M Schmainda Journal: AJNR Am J Neuroradiol Date: 2015-06-11 Impact factor: 3.825
Authors: Melissa A Prah; Mona M Al-Gizawiy; Wade M Mueller; Elizabeth J Cochran; Raymond G Hoffmann; Jennifer M Connelly; Kathleen M Schmainda Journal: J Neurooncol Date: 2017-09-12 Impact factor: 4.130